Structures by: Lee H. W.
Total: 8
C10H12F2N2O5
C10H12F2N2O5
Journal of medicinal chemistry (2019) 62, 13 6346-6362
a=5.8735(2)Å b=13.5166(5)Å c=14.1374(5)Å
α=90° β=90° γ=90°
C11H13F2N5O3,1.5(H2O)
C11H13F2N5O3,1.5(H2O)
Journal of medicinal chemistry (2019) 62, 13 6346-6362
a=10.20373(8)Å b=6.97368(6)Å c=18.69692(15)Å
α=90° β=96.8278(7)° γ=90°
C10H13FN2O5
C10H13FN2O5
Journal of medicinal chemistry (2019) 62, 13 6346-6362
a=6.6465(2)Å b=6.6465(2)Å c=43.3632(14)Å
α=90° β=90° γ=120°
C10H14N2O4Se
C10H14N2O4Se
Organic letters (2010) 12, 10 2242-2245
a=9.2745(7)Å b=5.2059(3)Å c=12.1233(7)Å
α=90.00° β=92.047(2)° γ=90.00°
C70.73H50.94Cl3.53Co5N34O0.74S2
C70.73H50.94Cl3.53Co5N34O0.74S2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 16 6229-6235
a=12.9626(4)Å b=16.2465(7)Å c=18.6106(9)Å
α=80.411(3)° β=89.948(3)° γ=88.872(3)°
Strontium perchlorate anhydrate
2(ClO4),Sr
Acta Crystallographica Section E (2019) 75, 4 447-450
a=14.18206(10)Å b=9.78934(11)Å c=9.37624(10)Å
α=90.0° β=90.0° γ=90.0°
Nicotinium tetrachlorocuprate(II)
C10H16N22,Cl4Cu2
Acta Crystallographica Section E (2002) 58, 10 m583-m585
a=7.6919(8)Å b=8.1526(9)Å c=12.2337(15)Å
α=87.249(9)° β=88.694(8)° γ=89.414(7)°
Methanoldinitrato[<i>N</i>-(2-pyridylmethylene)aniline]copper(II)
C13H14CuN4O7
Acta Crystallographica Section E (2009) 65, 11 m1362
a=14.5924(13)Å b=13.4826(12)Å c=17.0060(13)Å
α=90° β=90° γ=90°